Gyre Therapeutics Inc
NASDAQ:GYRE

Watchlist Manager
Gyre Therapeutics Inc Logo
Gyre Therapeutics Inc
NASDAQ:GYRE
Watchlist
Price: 8.13 USD 4.23% Market Closed
Market Cap: 762.1m USD

Wall Street
Price Targets

GYRE Price Targets Summary
Gyre Therapeutics Inc

Wall Street analysts forecast GYRE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GYRE is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.

Lowest
Price Target
20.2 USD
148% Upside
Average
Price Target
20.4 USD
151% Upside
Highest
Price Target
21 USD
158% Upside
Gyre Therapeutics Inc Competitors:
Price Targets
IKT
Inhibikase Therapeutics Inc
332% Upside
251120
Bio-FD&C Co Ltd
2% Upside
STOK
Stoke Therapeutics Inc
99% Upside
1801
Innovent Biologics Inc
22% Downside
AMRN
Amarin Corporation PLC
18% Downside
CRSP
CRISPR Therapeutics AG
57% Upside
302440
SK Bioscience Co Ltd
18% Downside
VIR
Vir Biotechnology Inc
247% Upside

Revenue
Forecast

Revenue Estimate
Gyre Therapeutics Inc

For the last 8 years the compound annual growth rate for Gyre Therapeutics Inc's revenue is 101%. The projected CAGR for the next 3 years is 51%.

101%
Past Growth
51%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Gyre Therapeutics Inc

The compound annual growth rate of Gyre Therapeutics Inc's operating income for the next 3 years is 130%.

N/A
Past Growth
130%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Gyre Therapeutics Inc

The compound annual growth rate of Gyre Therapeutics Inc's net income for the next 3 years is 139%.

N/A
Past Growth
139%
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GYRE's stock price target?
Price Target
20.4 USD

According to Wall Street analysts, the average 1-year price target for GYRE is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.

What is Gyre Therapeutics Inc's Revenue forecast?
Projected CAGR
51%

For the last 8 years the compound annual growth rate for Gyre Therapeutics Inc's revenue is 101%. The projected CAGR for the next 3 years is 51%.

What is Gyre Therapeutics Inc's Operating Income forecast?
Projected CAGR
130%

The compound annual growth rate of Gyre Therapeutics Inc's operating income for the next 3 years is 130%.

What is Gyre Therapeutics Inc's Net Income forecast?
Projected CAGR
139%

The compound annual growth rate of Gyre Therapeutics Inc's net income for the next 3 years is 139%.

Back to Top